Conquer Fear Carer Brief: A Quick Online Therapy for Caregivers Facing Cancer Progression

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project tests a three-session online intervention, Conquer Fear Carer Brief, designed for caregivers of patients with metastatic cancer. The study focuses on feasibility and acceptability, including dropout rates, consent rates, and therapist fidelity, as well as changes in caregiver fear using a caregiver-adapted FCRI. Secondary aims explore direction of change in additional caregiver outcomes and how participants understand and apply the content. The trial uses standardized questionnaires and a small sample to determine if a full study is warranted.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Self-identified caregiver of a patient with metastatic, non-curable cancer
* Aged ≥18 years
* Score in the clinical range (≥22) on the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF)
* Score in the clinical range (\>15) on the Brief Penn State Worry Questionnaire (PSWQ)
* Sufficient proficiency in Danish
* Able to provide informed consent
* Stable or no use of antidepressant or anxiolytic medication (i.e., stable dosage for ≥6 weeks)
* Able to participate in online-delivered therapy via a computer with a video camera

Exclusion Criteria:

* Severe psychiatric conditions (e.g., major depression) that would make participation in the intervention inappropriate
* Currently enrolled in psychotherapy or counseling targeting the same problem
* Substance abuse or dependence judged to require treatment
* Suicide risk requiring immediate psychiatric intervention or hospitalization

Where it's running

• Department of Psychology and Behavioural Sciences, Aarhus University
  Aarhus, Denmark Recruiting

Study contacts

• Study coordinator: Cecilie R Buskbjerg, PhD
• Email: cdrc@psy.au.dk
• Phone: +4529842526

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Managing fear of cancer progression with different psychological approaches

  This study is testing two different therapy programs to see if they can help Chinese patients with advanced cancer feel less afraid of their illness getting worse.

  Recruiting at 2 sites The University of Hong Kong · Hong Kong and 3 other locations · NCT05679518

• Bioimpedance Spectroscopy for Fluid Changes in Hemodialysis Patients

  This study tests whether raw bioimpedance data can help doctors gauge fluid changes in people on hemodialysis and guides fluid removal decisions.

  Recruiting University of Aarhus · Aarhus, Central Denmark · NCT07803029

• PRODIAP: See if patient-reported outcomes improve care for people with type 2 diabetes in general practice

  A large Danish trial tests whether using a diabetes-specific patient-reported outcomes questionnaire in general practice helps tailor care for people with type 2 diabetes.

  Recruiting University of Aarhus · Aarhus · NCT07767331

• Tailored rehab for young adults with cancer

  This pilot trial tests a youth-focused rehabilitation program called YATAC to see if it’s feasible and acceptable for adults 18-39 with cancer who are in municipal rehab settings.

  Recruiting University of Aarhus · Aarhus · NCT07692763

• Nitrous Oxide in Blood, Breath, and Urine After Different Exposures

  This study tests how nitrous oxide appears in blood, breath, and urine after three different exposures in adults.

  Recruiting University of Aarhus · Aarhus · NCT07690358

• Disrupted congestion in acute heart failure: can ultrasound at discharge predict readmission and death

  This study tests whether ultrasound checks of congestion at discharge can predict which patients with acute heart failure are more likely to be readmitted or die within 90 days.

  Recruiting University of Aarhus · Aarhus and 2 other locations · NCT07682298

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.